WIB-Seattle: A Discussion on Entrepreneurship With H. Stewart Parker

H. Stewart Parker, IDRI CEO and long-time biotech executive, will lead a discussion on Feb. 20 in Seattle focused on key lessons and strategies for successful entrepreneurship. Ms. Parker founded Targeted Genetics Corporation, Immunex’s second spin-off, in 1992 and held the position of President and CEO from the company’s inception until November of 2008. She currently serves as a member of the board of directors for several for-profit and non-profit companies including C3 Jian, Oncogenex Pharmaceuticals, Copper Canyon Press, and the University of Washington College of Arts & Sciences. For more information on how to register, click here.